| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1478 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 661 | 2022 |
| The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, ... NPJ breast cancer 7 (1), 150, 2021 | 184 | 2021 |
| The impact of miRNA in colorectal cancer progression and its liver metastases O Balacescu, D Sur, C Cainap, S Visan, D Cruceriu, R Manzat-Saplacan, ... International journal of molecular sciences 19 (12), 3711, 2018 | 143 | 2018 |
| Chimeric antigen receptor T-cell therapy for colorectal cancer D Sur, A Havasi, C Cainap, G Samasca, C Burz, O Balacescu, I Lupan, ... Journal of clinical medicine 9 (1), 182, 2020 | 66 | 2020 |
| Antinuclear antibodies: marker of diagnosis and evolution in autoimmune diseases LM Sur, E Floca, DG Sur, MC Colceriu, G Samasca, G Sur Laboratory medicine 49 (3), e62-e73, 2018 | 61 | 2018 |
| Circulating tumor cells in clinical research and monitoring patients with colorectal cancer C Burz, VV Pop, R Buiga, S Daniel, G Samasca, C Aldea, I Lupan Oncotarget 9 (36), 24561, 2018 | 58 | 2018 |
| The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through# INPST hashtag analysis RK Singla, R De, T Efferth, B Mezzetti, MS Uddin, F Ntie-Kang, D Wang, ... Phytomedicine 108, 154520, 2023 | 41 | 2023 |
| The relevance of inflammatory markers in metabolic syndrome SUR Genel, E Floca, L Kudor-Szabadi, ML Sur, SUR Daniel, G Samasca Maedica 9 (1), 15, 2014 | 34 | 2014 |
| Diagnostic value of artificial intelligence-assisted endoscopic ultrasound for pancreatic cancer: a systematic review and meta-analysis EA Dumitrescu, BS Ungureanu, IM Cazacu, LM Florescu, L Streba, ... Diagnostics 12 (2), 309, 2022 | 31 | 2022 |
| Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on … J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, ... The Journal of pathology 260 (5), 498-513, 2023 | 28 | 2023 |
| MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis D Sur, S Advani, D Braithwaite Frontiers in Medicine 9, 915226, 2022 | 28 | 2022 |
| Papillary thyroid carcinoma in children with Hashimoto’s thyroiditis–a review of the literature between 2000 and 2020 ML Sur, R Gaga, C Lazăr, C Lazea, C Aldea, D Sur Journal of Pediatric Endocrinology and Metabolism 33 (12), 1511-1517, 2020 | 28 | 2020 |
| Arterial hypertension–prevalence of risk factors and morbide associations that increase cardiovascular risk G Sur, M Sur, L Kudor-Szabadi, L Sur, D Sporis, D Sur Maedica 5 (1), 34, 2010 | 28 | 2010 |
| The role of miRNA-31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs D Sur, C Cainap, C Burz, A Havasi, IC Chis, C Vlad, V Milosevic, ... J buon 24 (5), 1739-1746, 2019 | 24 | 2019 |
| MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer DG Sur, M Colceriu, G Sur, C Aldea, C Silaghi, G Samasca, I Lupan, ... Expert Review of Proteomics 16 (10), 851-856, 2019 | 23 | 2019 |
| Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast … DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, ... The Journal of pathology 260 (5), 514-532, 2023 | 22 | 2023 |
| Impacts of biomedical hashtag-based Twitter campaign:# DHPSP utilization for promotion of open innovation in digital health, patient safety, and personalized medicine M Kletecka-Pulker, H Mondal, D Wang, RG Parra, AY Maigoro, S Lee, ... Current Research in Biotechnology 3, 146-153, 2021 | 22 | 2021 |
| Colorectal cancer: evolution of screening strategies D Sur, M Colceriu, G Sur, E Floca, L Dascal, A Irimie Medicine and pharmacy reports 92 (1), 21, 2019 | 22 | 2019 |
| Oncolytic virotherapy: A new paradigm in cancer immunotherapy SR Volovat, DV Scripcariu, IA Vasilache, CR Stolniceanu, C Volovat, ... International journal of molecular sciences 25 (2), 1180, 2024 | 21 | 2024 |
Ovidiu BalacescuSenior researcher, The Oncology Institute "Prof Dr. Ion Chiricuta" Cluj-NapocaCorreu electrònic verificat a iocn.ro
